Yanni Chen

Yanni Chen has a diverse work experience spanning various roles in the biopharmaceutical industry. Yanni is currently working as the Preclinical Research Head- Oncology at IMMORNA since March 2021, where they provide technical leadership in the immune-oncology program tech transfer. Before that, Yanni worked at Jemincare as the Director from May 2018 to March 2021. Prior to that, they were a Principle Investigator at BlueRay Biopharma Research from April 2017 to May 2018, and a Senior Scientist II at ChemPartner from October 2016 to March 2017. Yanni also has experience as a Scientist at Novartis Oncology from July 2013 to September 2016. Yanni started their career as an Assistant Professor at the Wuhan Institute of Virology, Chinese Academy of Science from December 2011 to June 2013.

Yanni Chen completed their education history as follows. Yanni attended Wuhan University from 2001 to 2005, where they studied Biotechnology. After that, they pursued a Master's degree in Microbiology and Virology from 2005 to 2007 at the same university. Finally, they continued their education at Wuhan University and obtained a Doctor of Science degree in Microbiology and Virology from 2008 to 2011.